Amy Compton-Phillips - 31 May 2025 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP, Chief Medical Officer
Signature
/s/ Amy Compton-Phillips
Issuer symbol
CVS
Transactions as of
31 May 2025
Net transactions value
+$3,399,948
Form type
4
Filing time
03 Jun 2025, 16:33:21 UTC
Previous filing
07 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Compton-Phillips Amy EVP, Chief Medical Officer ONE CVS DRIVE, WOONSOCKET /s/ Amy Compton-Phillips 03 Jun 2025 0001741492

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (RSUs) Award $2,999,954 +46,845 $64.04 46,845 31 May 2025 Direct F1
transaction CVS Common Stock (RSUs) Award $399,994 +6,246 +13% $64.04 53,091 31 May 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $0 +27,081 $0.000000 27,081 31 May 2025 Common Stock 27,081 $64.04 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 5/31/2026.
F2 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 5/31/2026.
F3 Option becomes exercisable in four equal annual installments, commencing 5/31/2026.